News about Global Pharma

Celltrion Announces Three-Stage Strategy to Counter Trump's Pharma Tariff Plan

Celltrion has announced its response strategy to US President Donald Trump’s plan to impose tariffs on pharmaceuticals.

Global Pharma | 10/07/2025 | By Dineshwori |  541

MolecuLight Appoints Dr. Julia Wright, MD, FACP, as its New Chief Medical Officer

MolecuLight Inc. announced the appointment of Dr. Julia Wright, MD, FACP, as its new Chief Medical Officer (CMO). In this pivotal role, Dr. Wright will lead MolecuLight's global medical and clinical strategy.

Global Pharma | 10/07/2025 | By Manvi |  219

Sandoz Begins Construction Of USD 440 Million Biosimilars Production Facility In Slovenia

Sandoz is constructing a new facility in Slovenia to strengthen its European biosimilar hub and expand its global market presence.

Global Pharma | 10/07/2025 | By Dineshwori |  540

Centrient Pharmaceuticals Appoints New Site Director for Delft Facility

Centrient Pharmaceuticals has announced the appointment of Pierre-Yves Dalla-Libera as the new Site Director for its Delft facility, effective September 1, 2025.

Global Pharma | 10/07/2025 | By Dineshwori |  764

Merck to Acquire Verona Pharma for USD 10 Billion to Expand Cardio-Pulmonary Portfolio

Merck, through a subsidiary, will acquire Verona Pharma for USD 107 per American Depository Share (ADS), each of which represents eight shares of Verona Pharma, for a total transaction value of approximately USD 10 billion.

Global Pharma | 10/07/2025 | By Dineshwori |  494

Global API Market Expected to Reach USD 422.8 Billion by 2034

The global Active Pharmaceutical Ingredients (API) market is projected to grow at a compound annual growth rate (CAGR) of 6.7 percent to an estimated USD 422.8 billion by 2034, according to a report.

Global Pharma | 09/07/2025 | By Dineshwori |  250

Lupin Signs USD 50 million Deal with Zentiva to Commercialise Biosimilar Certolizumab Pegol Globally

Zentiva will be responsible for marketing and distribution of Lupin’s biosimilar Certolizumab Pegol outside the USA and Canada—primarily across Europe and the CIS (Commonwealth of Independent States) region.

Global Pharma | 09/07/2025 | By Dineshwori |  396

Nectar to Sell API, Formulations and Menthol Units to Ceph for INR 1,290 Cr

Nectar Lifesciences Ltd. is selling its core business division for INR 1,270 crore and its menthol business for INR 20 crore to Ceph Lifesciences.

Global Pharma | 09/07/2025 | By Dineshwori |  1079

GSK Completes Acquisition of Efimosfermin from Boston Pharmaceuticals for USD 2 Billion

GSK has completed its acquisition of efimosfermin alfa, a Phase III-ready investigational therapy for serious liver diseases, from Boston Pharmaceuticals in a deal worth up to USD 2 billion.

Global Pharma | 09/07/2025 | By Mrinmoy Dey |  453

Mold-Tek Projects INR 30-35 Crore from Pharma Segment in FY26

Hyderabad-based Mold-Tek Packaging is witnessing strong growth in its pharmaceutical packaging segment, with ambitious targets of INR 30–35 crore in revenue for FY26 and INR 50–60 crore by FY27.

Global Pharma | 08/07/2025 | By Manvi |  234